Piroxicam,a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation

Background piroxicam (px) belongs to the oxicam group of the non-steroidal anti-inflammatory drugs (nsaids) and have been shown to exert chemopreventive and chemotherapeutic effects in animal models and cultured animal cells. however,little is known about the mode of action of px and its cellular targets. methods we explored the role of px,in triggering apoptosis and examined the involvement of upstream cellular mechanisms in apoptosis induction by px. results and discussion our studies with human breast cancer cells mcf-7 show that px induces reactive oxygen species (ros) generation along with apoptotic cell death. ros release lead to akt activation. on evaluation it became evident that ros mediated apoptosis induction was due to akt activation (hyper phosphorylation). silencing the expression of akt using sirna and a specific akt inhibitor,triciribine further confirmed the findings. however px failed to cause ros generation,cell death or akt phosphorylation in another human breast cancer cells mda-mb-231 which is estrogen receptor negative and more aggressive compared to mcf-7 cells. this suggests that px has cell type specific effects. thus we revealed for the first time that px can induce apoptosis by ros mediated akt hyperphosphorylation/activation. © 2015 institute of pharmacology,polish academy of sciences. published by elsevier sp. z o.o. all rights reserved.